高佳, 刘彦慧, 阎玲, 陈小岑, 赵路军. 脑转移瘤瘤周水肿相关分子生物学因素研究进展[J]. 中国肿瘤临床, 2014, 41(8): 534-537. DOI: 10.3969/j.issn.1000-8179.20132122
引用本文: 高佳, 刘彦慧, 阎玲, 陈小岑, 赵路军. 脑转移瘤瘤周水肿相关分子生物学因素研究进展[J]. 中国肿瘤临床, 2014, 41(8): 534-537. DOI: 10.3969/j.issn.1000-8179.20132122
GAO Jia, LIU Yanhui, YAN Ling, CHEN Xiaocen, ZHAO Lujin. Research progress on peritumoral edema-related molecular biology factors of the metastasis tumor of brain[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 41(8): 534-537. DOI: 10.3969/j.issn.1000-8179.20132122
Citation: GAO Jia, LIU Yanhui, YAN Ling, CHEN Xiaocen, ZHAO Lujin. Research progress on peritumoral edema-related molecular biology factors of the metastasis tumor of brain[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 41(8): 534-537. DOI: 10.3969/j.issn.1000-8179.20132122

脑转移瘤瘤周水肿相关分子生物学因素研究进展

Research progress on peritumoral edema-related molecular biology factors of the metastasis tumor of brain

  • 摘要: 脑转移瘤瘤周水肿指脑转移肿瘤周围脑实质内水分的异常增多,是影响患者生活质量和治疗疗效的关键因素之一,其发生机制复杂,影响因素众多。可能与血管内皮生长因子及其受体、水通道蛋白-4、金属基质蛋白酶-9、白细胞介素-6、乏氧诱导因子及其他分子生物学因素有关,上述分子生物学因素的深入研究可以为瘤周水肿的防治、监测、治疗及预后提供依据。瘤周水肿的治疗除传统的脱水治疗外,相关分子生物学因素的运用可以为其提供新的途径和方向,其中水通道蛋白-4激动剂或拮抗剂,血管内皮生长因子受体拮抗剂已逐步在临床中得到初步应用。本文就脑转移瘤瘤周水肿相关分子生物学因素进行综述。

     

    Abstract: Peritumoral edema (PTE) of the metastasis tumor of brain (MTB) refers to the abnormal increase of moisture in the surrounding cerebral parenchyma of the brain tumor. The mechanism of PTE occurrence of MTB is complicated, and the influencing factors are diverse. PTE is one of the key factors that affect patient survival and cure. Researchers from China and overseas believe that it may be related to the expression of the vascular endothelial growth factor (VEGF) or VEGF receptor, aquaporin-4 (AQP-4), matrix metalloproteinase-9, interleukin-6, hypoxia inducible factor-1a, and other molecular biology factors. Studies of these molecular biological factors provide objective scientific evidence for the prevention, control, monitoring, treatment, and prognosis of PTE of metastasized brain tumor. In addition to the traditional dehydration therapy of PTE, the use of PTE-related molecular biological factors provides a new approach for the treatment. AQP-4 agonists or antagonists and VEGF receptor antagonists also have good therapeutic potentials. In this paper, the authors reviewed the PTE-related molecular biological factors of MTB.

     

/

返回文章
返回